Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
9.30
+0.18 (1.97%)
Oct 29, 2025, 10:38 AM EDT - Market open
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $780.96 million as of October 29, 2025. Its market cap has increased by 74.19% in one year.
Market Cap
780.96M
Enterprise Value
822.49M
1-Year Change
74.19%
Ranking
Category
Stock Price
$9.30
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $780.96M, an increase of 73.18%. That is a compound annual growth rate of 4.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 791.71M | 117.80% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | 862.29M | 228.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |